These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17171295)

  • 1. Mitochondrial permeability transition in cardiac cell injury and death.
    Honda HM; Ping P
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):425-32. PubMed ID: 17171295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia.
    Ruiz-Meana M; Inserte J; Fernandez-Sanz C; Hernando V; Miro-Casas E; Barba I; Garcia-Dorado D
    Basic Res Cardiol; 2011 Nov; 106(6):1259-68. PubMed ID: 21959501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
    Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
    Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy.
    Hamacher-Brady A; Brady NR; Gottlieb RA
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):445-62. PubMed ID: 17149555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the mitochondrial permeability transition in myocardial disease.
    Weiss JN; Korge P; Honda HM; Ping P
    Circ Res; 2003 Aug; 93(4):292-301. PubMed ID: 12933700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postconditioning attenuates cardiocyte ultrastructure injury and apoptosis by blocking mitochondrial permeability transition in rats.
    Fang J; Wu L; Chen L
    Acta Cardiol; 2008 Jun; 63(3):377-87. PubMed ID: 18664030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria and Pharmacologic Cardiac Conditioning-At the Heart of Ischemic Injury.
    Lotz C; Herrmann J; Notz Q; Meybohm P; Kehl F
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33810024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinapic acid protects heart against ischemia/reperfusion injury and H9c2 cardiomyoblast cells against oxidative stress.
    Silambarasan T; Manivannan J; Priya MK; Suganya N; Chatterjee S; Raja B
    Biochem Biophys Res Commun; 2015 Jan; 456(4):853-9. PubMed ID: 25511706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis.
    Javadov S; Hunter JC; Barreto-Torres G; Parodi-Rullan R
    Cell Physiol Biochem; 2011; 27(3-4):179-90. PubMed ID: 21471706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria in Ischemic Heart Disease.
    Maximilian Buja L
    Adv Exp Med Biol; 2017; 982():127-140. PubMed ID: 28551785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PROBLEM OF END EFFECTOR OF ISCHEMIC PRECONDITIONING OF THE HEART].
    Tsibulnikov SY; Maslov LN; Tsepokina AV; Khutomaya MV; Kutikhin AG; Tsibulnikova MR; Nam IF
    Ross Fiziol Zh Im I M Sechenova; 2016 Apr; 102(4):421-35. PubMed ID: 30188674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria and ischemia/reperfusion injury.
    Honda HM; Korge P; Weiss JN
    Ann N Y Acad Sci; 2005 Jun; 1047():248-58. PubMed ID: 16093501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial injury and protection in ischemic pre- and postconditioning.
    Di Lisa F; Canton M; Carpi A; Kaludercic N; Menabò R; Menazza S; Semenzato M
    Antioxid Redox Signal; 2011 Mar; 14(5):881-91. PubMed ID: 20615074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RISK pathway leading to mitochondria and cardioprotection: how everything started.
    Yellon DM; Beikoghli Kalkhoran S; Davidson SM
    Basic Res Cardiol; 2023 May; 118(1):22. PubMed ID: 37233787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
    Luo T; Chen B; Zhao Z; He N; Zeng Z; Wu B; Fukushima Y; Dai M; Huang Q; Xu D; Bin J; Kitakaze M; Liao Y
    Basic Res Cardiol; 2013 May; 108(3):342. PubMed ID: 23467745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of mitochondrial permeability transition pore.
    Duan X; Ji B; Yu K; Liu J; Hei F; Long C
    ASAIO J; 2011; 57(3):197-202. PubMed ID: 21317634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition.
    Leshnower BG; Kanemoto S; Matsubara M; Sakamoto H; Hinmon R; Gorman JH; Gorman RC
    Ann Thorac Surg; 2008 Oct; 86(4):1286-92. PubMed ID: 18805178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.